PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
43.32
+1.36 (3.24%)
Nov 21, 2024, 1:39 PM EST - Market open
PTC Therapeutics Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for PTC Therapeutics stock have an average target of 42.58, with a low estimate of 26 and a high estimate of 64. The average target predicts a decrease of -1.70% from the current stock price of 43.32.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for PTCT stock from 12 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Hold | 6 | 6 | 5 | 5 | 4 | 4 |
| Sell | 2 | 2 | 2 | 1 | 1 | 1 |
| Strong Sell | 3 | 3 | 3 | 3 | 3 | 2 |
| Total | 15 | 15 | 15 | 14 | 13 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $51 → $62 | Buy | Maintains | $51 → $62 | +43.13% | Nov 19, 2024 |
| Barclays | Barclays | Hold Maintains $43 → $45 | Hold | Maintains | $43 → $45 | +3.88% | Nov 14, 2024 |
| Barclays | Barclays | Hold Maintains $31 → $43 | Hold | Maintains | $31 → $43 | -0.73% | Nov 11, 2024 |
| Baird | Baird | Buy Maintains $44 → $48 | Buy | Maintains | $44 → $48 | +10.81% | Nov 8, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $32 → $45 | Hold | Maintains | $32 → $45 | +3.88% | Oct 11, 2024 |
Financial Forecast
Revenue This Year
762.12M
from 937.82M
Decreased by -18.74%
Revenue Next Year
712.36M
from 762.12M
Decreased by -6.53%
EPS This Year
-5.15
from -8.37
EPS Next Year
-3.67
from -5.15
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 841.1M | 911.0M | 1.3B | ||
| Avg | 762.1M | 712.4M | 855.6M | ||
| Low | 689.2M | 519.4M | 459.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -10.3% | 19.5% | 78.6% | ||
| Avg | -18.7% | -6.5% | 20.1% | ||
| Low | -26.5% | -31.8% | -35.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.87 | -0.81 | 2.61 | ||
| Avg | -5.15 | -3.67 | -1.55 | ||
| Low | -6.39 | -6.86 | -5.25 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.